Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
CRISPR
100%
Guide RNA
54%
Hematopoietic Cell
50%
Genome Editing
45%
CRISPR/Cas9
26%
Forkhead Transcription Factor
16%
Genotyping
16%
Gene Repair
16%
DNA Damage Response
16%
Adeno Associated Virus
16%
Missense Mutation
16%
Melanocyte
16%
P53
16%
CD34
16%
Macrobrachium rosenbergii
16%
Adenosine
16%
Inosine
16%
RNA Editing
16%
Autoimmunity
13%
Nuclease
12%
Genetics
11%
T Cell
11%
RNA
10%
Enzyme
8%
Signal Transduction
8%
Regulatory Element
8%
Cell Spreading
8%
Cancer Cell
8%
Pigmentation
8%
Normal Human
8%
Gene Mutation
8%
Tumor Progression
8%
Carcinogenesis
8%
Causal Relationship
8%
Cancer Model
8%
Gene Therapy
7%
Ribonucleoprotein
7%
Cluster of Differentiation
6%
Immunoregulation
5%
Pediatrics
5%
Electroporation
5%
Cas9 Protein
5%
Keyphrases
CRISPR Activation
25%
Genome Editing
20%
Hematopoietic Stem Cells
16%
CRISPR Technology
16%
Gene Therapy
16%
Severe Combined Immunodeficiency
16%
R273H
16%
Therapygenetics
16%
Genetic Disease
16%
Outcome Prediction
16%
Lessons Learned
16%
Colorectal Cancer Patients
16%
Israel
16%
Colorectal Cancer
16%
Tumor Protein p53 (TP53)
16%
Newborn Screening
16%
Clinically Significant
16%
Freshwater Prawn
16%
Macrobrachium Rosenbergii
16%
Platelet Defects
16%
Distinct Phenotype
16%
TP53 mutation
16%
A-to-I RNA Editing
16%
CRISPR Gene Editing
16%
Editing Efficiency
13%
RNA Editing
12%
Cancer Tumor
11%
Missense mutation
11%
Off-target Interactions
10%
Embryonic Cell Culture
8%
Functional Genomics
8%
Cluster of Differentiation 34
7%
Cell Cleavage
5%
Transcriptional Output
5%
Cancer Progression
5%
Transcriptional Signature
5%
Regulatory Elements
5%
Preferential Binding
5%
Treatment Understanding
5%
Bad Outcomes
5%
P53 Gene
5%
Cancer Cases
5%
Disease Features
5%
Cell Migration
5%
Migration/invasion
5%
Cell Spreading
5%
Colorectal Cancer Cells
5%
Cell Metastasis
5%
Oncogenic Signaling
5%
Metastatic Disease
5%
Immunology and Microbiology
Severe Combined Immunodeficiency
50%
Cell Line
30%
Clustered Regularly Interspaced Short Palindromic Repeat
27%
Gene Editing
27%
T Cell
22%
Genome Editing
20%
Newborn Screening
16%
Immunodeficiency
16%
Infancy
16%
DNA Damage Response
16%
Hematopoietic Cell
16%
Neutrophil
16%
Adeno Associated Virus
16%
RNA Editing
16%
Next Generation Sequencing
16%
Platelet
16%
Infectious Disease
15%
Infection
15%
Hematopoietic Stem Cell Transplantation
12%
Whole Exome Sequencing
11%
IPEX Syndrome
11%
Ribonucleic Acid
8%
T Cell Receptor
8%
Human Cell
7%
CRISPR/Cas9
6%
Multiplex Polymerase Chain Reaction
5%
Candida Albicans
5%
Hypogammaglobulinemia
5%
Pneumocystis
5%
Immunodeficiency
5%
Lymphocytopenia
5%
